CompletedNot Applicable

ABTHERA ADVANCE™ Use Without Wittman Patch

United States3 participantsStarted 2020-10-12

Plain-language summary

The objective of this study is to evaluate the use of the ABTHERA ADVANCE for patients requiring open abdomen due to necrotizing pancreatitis. The institutions traditional approach is to use the ABTHERA Open Abdomen dressing with Wittmann patch. However, the ABTHERA ADVANCE has shown in vitro to have improved tension on the abdominal wall that may obviate the need for costly Wittmann patch placement.

Who can participate

Age range22 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Male or Female patients aged ≥ 22 * Severe necrotizing pancreatitis with abdominal compartment syndrome or severe sepsis requiring decompressive laparotomy and/or pancreatic debridement * Patients that require open abdomen at the conclusion of their index operation Exclusion Criteria: * Female patients who are pregnant or lactating * If in the opinion of the treating physician a patient should not participate in this study.

What they're measuring

Cost Saving

Timeframe: 3 months after the last participant has been enrolled.

Trial details

NCT IDNCT04986943

SponsorWake Forest University Health Sciences

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-03-28

View on ClinicalTrials.gov More Necrotizing Pancreatitis trials